Intravenous mycophenolate mofetil (MMF) after allogeneic blood stem cell transplantation.: Results of a dose-finding study.

被引：0
|
作者：
Renner, U
Platzbecker, U
Freiberg-Richter, J
Plettig, R
Helwig, A
Schäfer, K
Wandt, H
Ehninger, G
Bornhauser, M
机构：
[1] Univ Hosp, Med Clin 1, Dresden, Germany
[2] Klinikum Nord, Med Clin 5, Nuernberg, Germany
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
681
引用
收藏
页码：156A / 156A
页数：1
相关论文
共 50 条
  • [1] GVHD prophylaxis with mycophenolate mofetil and cyclosporin A after allogeneic blood stem cell transplantation. Results of a pilot study.
    Bornhauser, M
    Thiede, HM
    Schuler, U
    Thiede, C
    Ehninger, G
    BLOOD, 1997, 90 (10) : 462 - 462
  • [2] Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation
    Jenke, A
    Renner, U
    Richter, M
    Freiberg-Richter, J
    Platzbecker, U
    Helwig, A
    Thiede, HM
    Schäfer-Eckart, K
    Ehninger, G
    Bornhauser, M
    CLINICAL TRANSPLANTATION, 2001, 15 (03) : 176 - 184
  • [3] Mycophenolate mofetil and CSA as GVHD prophylaxis after allogeneic blood stem cell transplantation.
    Bornhauser, M
    Thiede, HM
    Schuler, SU
    Thiede, C
    Ehninger, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S117 - S117
  • [4] Thymoglobulin as part of conditioning in unrelated donor allogeneic stem cell transplantation.: A dose-finding study
    Remberger, M
    Svahn, BM
    Mattsson, J
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2004, 33 : S44 - S44
  • [5] Pharmacokinetics of mycophenolate mofetil after blood stem cell transplantation.: Impact of conditioning therapy
    Jenke, A
    Renner, U
    Freiberg-Richter, J
    Röllig, C
    Babatz, J
    Ehninger, G
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S183 - S183
  • [6] Intravenous mycophenolate mofetil plus prednisolone and cyclosporine in the prophylaxis of GvHD after stem cell transplantation.
    Kiehl, MG
    Armstrong, V
    Basara, N
    Blau, IW
    Oellerich, M
    Fauser, AA
    BLOOD, 1999, 94 (10) : 153A - 153A
  • [7] Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.
    Freiberg-Richter, Jens
    Hantzschel, Ingmar
    Jenke, Andreas
    Lorenz, Petra
    Ehninger, Gerhard
    Bornhaeuser, Martin
    BLOOD, 2006, 108 (11) : 227A - 227A
  • [8] CAECUM PERFORATION CAUSED BY MYCOPHENOLATE MOFETIL (MMF) AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Karagun, B.
    Akbas, T.
    Arpaci, T.
    Ozcan, N.
    Cesur, I.
    Serbest, M.
    Sasmaz, I.
    Antmen, B.
    LEUKEMIA RESEARCH, 2015, 39 : SS41 - SS41
  • [9] The combination of mycophenolate mofetil, cyclosporine A and methotrexate for prophylaxes of acute GVHD in allogeneic peripheral blood stem cell transplantation.
    Wang, JM
    Song, XM
    Zhang, WP
    Tong, SP
    Hou, J
    Chen, L
    Li, H
    Min, BH
    BLOOD, 2001, 98 (11) : 662A - 662A
  • [10] Use of Mycophenolate Mofetil (MMF) in renal transplantation. Results of a single-centre trial
    Pastural, M
    Barrou, B
    Golmard, JL
    Gorichon-Radideau, E
    Manighetti, J
    Ourahma, S
    Benalia, H
    Mouquet, C
    Chatelain, C
    Bitker, MO
    PROGRES EN UROLOGIE, 1999, 9 (01): : 19 - 25
12345